article thumbnail

3 Ways AI Can Detect Vital Signs From Your Face

The Medical Futurist

Recently, a new trend has emerged where artificial intelligence (AI)-based apps are detecting vital signs as well as possible illness indicators from patients’ faces alone. Determining patients’ prognosis Due to individual variations in genetics and lifestyle choices, each person ages at a different rate.

article thumbnail

Aftershock in Academia: Assessing COVID-19s Impact on Schizophrenia Patients in Academic Medical Centers [Behavioral, psychosocial, and mental illness]

Annals of Family Medicine

Context: The impact of the COVID-19 pandemic on individuals with schizophrenia who are admitted to academic medical centers (AMCs) has not been previously reported. from Oct 2019 to Dec 2023. The study is divided into three periods: pre-COVID (Oct 2019 to Mar 2020), COVID (Apr 2020 to May 2023), and post-COVID (Jun 2023 to Dec 2023).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Long Time Coming: DEA Regs Finally Authorize Schedule II Prescription Partial Fills

FDA Law Blog

Now, in July 2023, DEA has finally issued its final rule amending its regulations for partial filling of prescriptions for schedule II substances. 46,983 (July 21, 2023). Partial Filling of Prescriptions for Schedule II Controlled Substances, 85 Fed. 78,282 (Dec. The Final Rule a. b)(5)(i)). (2) codified at 21 C.F.R. b)(5)(ii)).

article thumbnail

Parvo Podcast! Erythema Infectiosum, Fifth Disease, and more!

PEMBlog

Recognize key diagnostic features that help differentiate Parvovirus B19 from other viral exanthems and systemic illnesses. These are a group of viral rash-causing illnesses that were originally numbered in the late 19th and early 20th centuries based on their order of description. UpToDate , Jun. Parvoviruses. Erythema Infectiosum.

article thumbnail

AstraZeneca’s Challenge to Price Negotiation Fails in Federal District Court

FDA Law Blog

According to AstraZeneca, the statute defines a qualifying single source drug by reference to its individual “approval,” and “any other reading. 16 June 2023) Eliquis Novartis D.N.J. (1 2023) Entresto J&J’s Janssen Pharms. 18 July 2023) Xarelto Stelara Novo Nordisk D.N.J. (29 2023) Jardiance Merck D.D.C. (6

article thumbnail

Pet Food Institute Proposes Modernization of Pet Food and Treats Regulation

FDA Law Blog

PFI expressed some of its frustration with the current state of regulation of pet food by individual states in its comments on the Center for Veterinary Medicine (CVM) Virtual Public Meeting FDA and the AAFCO Animal Feed Ingredient Definition Process. PFI has noted that it is not feasible to develop and label products for an individual state.

article thumbnail

You don’t need labs to medically clear a psych patient

PEMBlog

Patients with psychosis caused by medical illness usually have abnormal vital signs, altered mental status, and impaired orientation with compromised intellectual function. Laboratory evaluation should be based on individual patient history and exam. Hosp Pediatr (2023) 13 (1): 66–71